deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03247738

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI (CANTIC)

Platelet Inhibition With CANgrelor and Crushed TICagrelor in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: The CANTIC Study

Sponsor: Chiesi Farmaceutici S.p.A.

Conditions Percutaneous Coronary Intervention ST Segment Elevation Myocardial Infarction
Interventions Cangrelor Placebo
Updated 11 times since 2017 Last updated: Aug 26, 2020 Started: Nov 20, 2017 Primary completion: Dec 13, 2018 Completion: Dec 13, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Percutaneous Coronary Intervention and ST Segment Elevation Myocardial Infarction, this trial is completed. The trial is conducted by Chiesi Farmaceutici S.p.A. and has accumulated 11 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshotNot Yet Recruiting~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotRecruiting~Jan 2019 – ~Mar 2020 · 14 months · monthly snapshotCompleted~Mar 2020 – ~Oct 2020 · 7 months · monthly snapshotCompleted~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 6 earlier versions

  1. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE4

  2. Mar 2020 — Oct 2020 [monthly]

    Completed PHASE4

  3. Jan 2019 — Mar 2020 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  4. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE4

  5. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  6. Sep 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chiesi Farmaceutici S.p.A.
  • University of Florida
Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations